SBI Securities’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.51K Buy
1,112
+99
+10% +$757 ﹤0.01% 1797
2025
Q4
$9.85K Buy
1,013
+1,001
+8,342% +$8.51K ﹤0.01% 1727
2025
Q3
$50 Buy
12
+1
+9% +$6 ﹤0.01% 3714
2025
Q2
$102 Hold
11
﹤0.01% 3532
2025
Q1
$107 Hold
11
﹤0.01% 3419
2024
Q4
$133 Buy
+11
New +$134 ﹤0.01% 3376

Other funds holding REPL

SBI Securities's REPL Position: Q1 2026 in Review

SBI Securities increased its Replimune Group (REPL) stake by 9.8% in Q1 2026, buying an estimated $757 and bringing the position to 1,112 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

SBI Securities first reported a position in REPL in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.85K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • SBI Securities held 1,112 shares of Replimune Group worth $8.51K as of Q1 2026.
  • SBI Securities bought 99 Replimune Group shares in Q1 2026, an estimated $757.
  • Replimune Group made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1797 holding.
  • SBI Securities first reported a position in Replimune Group in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Replimune Group position peaked at $9.85K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.